Rebopag 50 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Rebopag 50 mg Tablet is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn’t make enough blood cells.

Rebopag 50 mg Tablet contains ‘Eltrombopag’, which belongs to the class of ‘thrombopoietin receptor agonists’. Thrombopoietin is a glycoprotein hormone, stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Rebopag 50 mg Tablet works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Rebopag 50 mg Tablet helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

In some cases, Rebopag 50 mg Tablet can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to Rebopag 50 mg Tablet or any other medicines before starting Rebopag 50 mg Tablet. Consult the doctor if you are pregnant or planning to conceive. Rebopag 50 mg Tablet is not indicated for use in breastfeeding since it passes into the breast milk.

VERY SECURE PAYMENT METHODS
SHIPPING WILL BE CALCULATED ON CHECKOUT
PLEASE NOTE THAT PRICES MAY INCREASE DUE TO EXCHANGE RATE, ENSURE UPDATED PRICE BEFORE MAKING PAYMENT